As of 2024-12-12, the Fair Value of Asarina Pharma AB (publ) (ASAP.ST) is -4.07 SEK. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.03 SEK, the upside of Asarina Pharma AB (publ) is -14,634.10%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -71.08 | -75.26 | -31.66 | -13.28 | -12.83 | -40.82 |
| YoY growth | -61.44% | -5.88% | 57.93% | 58.04% | 3.43% | 10.41% |
| Market Cap (mil) | 0.92 |
| P/E | |
| Forward P/E |
| EPS | -0.39 |
| Avg earnings growth rate | 10.41% |
| TTM earnings | -12.83 |